The statement said the stock of between 1 million and 1.4 million doses of the Pfizer-BioNTech vaccine “will expire soon” and indicates it is currently surplus to Israel’s requirements — though it is not clear how much time remains for Palestinian health authorities to administer the doses before expiration.
As part of the arrangement, a shipment of Pfizer vaccines intended for the PA later in the year will now be delivered to Israel instead.
Israel’s leaders won considerable international acclaim for the country’s highly successful rollout of Covid-19 vaccinations to its population of nine million earlier in the year.
Israel argued that it was relieved of those obligations by the Oslo Accords, signed by Israeli and Palestinian leaders in the 1990s, which allocate responsibility for medical care provision to the Palestinian Authority.
You may also like
-
Afghanistan: Civilian casualties hit record high amid US withdrawal, UN says
-
How Taiwan is trying to defend against a cyber ‘World War III’
-
Pandemic travel news this week: Quarantine escapes and airplane disguises
-
Why would anyone trust Brexit Britain again?
-
Black fungus: A second crisis is killing survivors of India’s worst Covid wave